Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)
暂无分享,去创建一个
D. Niederwieser | M. Herold | A. Franke | M. Freund | S. Hahnfeld | C. Klinkenstein | R. Pasold | C. Müller | For the Mucositis Study Group of the Multinational Ass Oncology | C. Boewer | C. Winkelmann | A. Schwarzer | K. Bremer | C. Müller | B. Ismer | M. Schulze | J. Weniger | K. Dachselt | H. Fricke | A. Schulze | P. Richter | V. Schirmer | H. Arzberger | C. Müller